We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Image: Findings demonstrate that AI can help classify meningiomas by extracting molecular and prognostic information from standard H&E slides already used in routine care. (Image Credit: Mikael Häggström, M.D./Wikimedia Commons, CC0 1.0)

AI Pathology Tool Predicts Meningioma Recurrence from Routine Slides

An AI approach reads routine H&E slides to classify meningiomas and predict recurrence. More...
10 Jun 2026
Image: New findings connect ribosome stress biology with blood-based small RNA biomarkers, highlighting the potential of liquid biopsy for lung cancer patient stratification (Image credit: 123RF)

Blood-Based RNA Test May Predict Chemotherapy Sensitivity in Lung Cancer

New findings link ribosome quality control to liquid-biopsy small RNAs, enabling lung cancer stratification and therapy guidance. More...
10 Jun 2026
Image: DNlite measures urinary post-translationally modified Fetuin-A (uPTM-FetA), a biomarker linked to kidney stress, inflammation, metabolic dysfunction, and progressive renal injury (Photo courtesy of Bio Preventive Medicine Corp)

Urinary Biomarker Assay Predicts Kidney Disease Progression Beyond Standard Measures

A new urinary biomarker assay may enable earlier and more precise risk stratification beyond albuminuria and eGFR. More...
10 Jun 2026
Image: Alpha-1 antitrypsin deficiency (ADD) is a progressive genetic condition, a major inherited risk factor for COPD, and a cause of liver disease in children and adults (Image credit: Adobe Stock)

Genetic Testing Program Expands Detection of Alpha-1 Antitrypsin Deficiency

Grifols was named an inaugural industry sponsor of a program advancing routine, targeted Alpha-1 detection in patients with liver or lung disease. More...
10 Jun 2026
Image: A simple blood test could help identify which patients with head and neck cancer are most likely to benefit from immunotherapy (image credit: Adobe Stock)

Blood Test Predicts Immunotherapy Response in Head and Neck Cancer

A blood-based cfDNA fragment test predicts pre-treatment immunotherapy response in head and neck cancer, outperforming biomarkers. More...
09 Jun 2026
Image: The modified culture medium speeds fidaxomicin resistance detection while reducing material and labor demands (image credit: Adobe Stock)

New Culture Medium Speeds C. difficile Resistance Detection and Reduces Costs

A modified culture medium speeds detection of fidaxomicin-resistant C. difficile with 100% sensitivity. More...
09 Jun 2026
Image: The fully automated solution increases vial loading by 50% and supports up to 960 vials per module, extending walk-away time (Photo courtesy of Waters Corporation)

Automated Blood Culture System Speeds Detection of Bloodstream Infections

The BD BACTEC FXI Culture System has received FDA 510(k) clearance and is now available to U.S. laboratories. More...
09 Jun 2026
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Online QC Software
Acusera 24•7
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
Automated Urinalysis Solution
UN-9000
ADLM